It was all set that Mexico was going to do a trial combining Leronlimab with Remdesivir. I think most folks thought that Dr Nader P. called off this trial. That may be true, but there were not many voices putting out theories of why the trial was cancelled. I think it was Mexico's idea to do this. Mexico was also looking at approving Leronlimab for m/m, and maybe they still will, maybe waiting for info on s/c Interim analysis???